These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2453798)

  • 1. The myotonic mouse mutant ADR: electrophysiology of the muscle fiber.
    Mehrke G; Brinkmeier H; Jockusch H
    Muscle Nerve; 1988 May; 11(5):440-6. PubMed ID: 2453798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myotonic mouse mutant ADR: physiological and histochemical properties of muscle.
    Reininghaus J; Füchtbauer EM; Bertram K; Jockusch H
    Muscle Nerve; 1988 May; 11(5):433-9. PubMed ID: 2967431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonia and neuromuscular transmission in the mouse.
    Költgen D; Brinkmeier H; Jockusch H
    Muscle Nerve; 1991 Aug; 14(8):775-80. PubMed ID: 1653899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of electrical myotonia in the ADR mouse: role of chloride conductance in myotubes and neonatal animals.
    Wischmeyer E; Nolte E; Klocke R; Jockusch H; Brinkmeier H
    Neuromuscul Disord; 1993 Jul; 3(4):267-74. PubMed ID: 8268723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of muscle chloride channel by transposon insertion in myotonic mice.
    Steinmeyer K; Klocke R; Ortland C; Gronemeier M; Jockusch H; Gründer S; Jentsch TJ
    Nature; 1991 Nov; 354(6351):304-8. PubMed ID: 1659665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications of gene expression in myotonic murine skeletal muscle are associated with abnormal expression of myogenic regulatory factors.
    Goblet C; Whalen RG
    Dev Biol; 1995 Aug; 170(2):262-73. PubMed ID: 7649361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental control of the excitability of muscle: transplantation experiments on a myotonic mouse mutant.
    Füchtbauer EM; Reininghaus J; Jockusch H
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3880-4. PubMed ID: 3375245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite regulation of the mRNAs for parvalbumin and p19/6.8 in myotonic mouse muscle.
    Kluxen FW; Schöffl F; Berchtold MW; Jockusch H
    Eur J Biochem; 1988 Sep; 176(1):153-8. PubMed ID: 3138114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Na+ channel activity and reduced Cl- conductance cause hyperexcitability in recessive generalized myotonia (Becker).
    Franke C; Iaizzo PA; Hatt H; Spittelmeister W; Ricker K; Lehmann-Horn F
    Muscle Nerve; 1991 Aug; 14(8):762-70. PubMed ID: 1716347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tocainide on normal and myotonic mammalian skeletal muscle.
    Dengler R; Rüdel R
    Arzneimittelforschung; 1979; 29(2):270-3. PubMed ID: 582139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of myosin-light-chain phosphorylation and of parvalbumin content in myotonic mouse muscle and its reversal by tocainide.
    Jockusch H; Reininghaus J; Stuhlfauth I; Zippel M
    Eur J Biochem; 1988 Jan; 171(1-2):101-5. PubMed ID: 3123225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schwartz-Jampel syndrome: II. Na+ channel defect causes myotonia.
    Lehmann-Horn F; Iaizzo PA; Franke C; Hatt H; Spaans F
    Muscle Nerve; 1990 Jun; 13(6):528-35. PubMed ID: 2164152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
    De Luca A; Pierno S; Liantonio A; Desaphy JF; Natuzzi F; Didonna MP; Ferrannini E; Jockusch H; Franchini C; Lentini G; Corbo F; Tortorella V; Camerino DC
    Neuromuscul Disord; 2004 Jul; 14(7):405-16. PubMed ID: 15210163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker).
    Rüdel R; Ricker K; Lehmann-Horn F
    Muscle Nerve; 1988 Mar; 11(3):202-11. PubMed ID: 3352655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice.
    Wu H; Olson EN
    J Clin Invest; 2002 May; 109(10):1327-33. PubMed ID: 12021248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle membrane chloride conductance and the myotonic syndromes.
    Barchi RL
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):559-70. PubMed ID: 285855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20,25-diazacholesterol myotonia: an electrophysiological study.
    Furman RE; Barchi RL
    Ann Neurol; 1981 Sep; 10(3):251-60. PubMed ID: 7294732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.
    Cannon SC; Corey DP
    J Physiol; 1993 Jul; 466():501-20. PubMed ID: 8105077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of myotonia produced by aromatic carboxylic acids.
    Furman RE; Barchi RL
    Ann Neurol; 1978 Oct; 4(4):357-65. PubMed ID: 727740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
    Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
    Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.